ImmuCell Corporation Increase (Decrease) in Accounts Payable, Trade
ImmuCell Corporation (ICCC) reported Increase (Decrease) in Accounts Payable, Trade of $42.77 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2017-11-13
- ImmuCell Corporation increase (decrease) in accounts payable, trade for the quarter ending 2017-09-30 was $47.72K, a 73.33% decline year-over-year.
- ImmuCell Corporation increase (decrease) in accounts payable, trade for the quarter ending 2017-06-30 was -$64.06K, a 232.91% decline year-over-year.
- ImmuCell Corporation increase (decrease) in accounts payable, trade for the quarter ending 2017-03-31 was $59.11K.
- ImmuCell Corporation increase (decrease) in accounts payable, trade for the quarter ending 2016-12-31 was -$154.98K, a 853.68% decline year-over-year.
- ImmuCell Corporation increase (decrease) in accounts payable, trade for fiscal 2016 was $58.29K.
- ImmuCell Corporation increase (decrease) in accounts payable, trade for fiscal 2015 was -$5.71K, a 211.99% decline from fiscal 2014.
- ImmuCell Corporation increase (decrease) in accounts payable, trade for fiscal 2014 was $5.09K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 3 month | Increase (Decrease) in Accounts Payable, Trade 6 month | Increase (Decrease) in Accounts Payable, Trade 9 month | Increase (Decrease) in Accounts Payable, Trade 12 month |
|---|---|---|---|---|
| 2017-09-30 | $47.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$16.34K derived: sum of 2 quarters · filed 2017-11-13 | $42.77K 10-Q · filed 2017-11-13 | -$112.21K derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-06-30 | -$64.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$4.95K 10-Q · filed 2017-08-14 | -$159.93K derived: sum of 3 quarters · filed 2017-08-14 | $19.01K derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | $59.11K 10-Q · filed 2017-05-11 | -$95.87K derived: sum of 2 quarters · filed 2017-05-11 | $83.06K derived: sum of 3 quarters · filed 2017-05-11 | $131.26K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | -$154.98K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $23.96K derived: sum of 2 quarters · filed 2017-03-30 | $72.15K derived: sum of 3 quarters · filed 2017-03-30 | $58.29K 10-K · filed 2017-03-30 |
| 2016-09-30 | $178.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $227.13K derived: sum of 2 quarters · filed 2016-11-10 | $213.27K 10-Q · filed 2016-11-10 | $233.83K derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | $48.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $34.34K 10-Q · filed 2016-08-11 | $54.90K derived: sum of 3 quarters · filed 2016-08-11 | $27.96K derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | -$13.86K 10-Q · filed 2016-05-11 | $6.71K derived: sum of 2 quarters · filed 2016-05-11 | -$20.23K derived: sum of 3 quarters · filed 2016-05-11 | -$18.73K derived: sum of 4 quarters · filed 2016-05-11 |
| 2015-12-31 | $20.56K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$6.37K derived: sum of 2 quarters · filed 2016-03-25 | -$4.87K derived: sum of 3 quarters · filed 2016-03-25 | -$5.71K 10-K · filed 2016-03-25 |
| 2015-09-30 | -$26.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$25.43K derived: sum of 2 quarters · filed 2015-11-12 | -$26.27K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $1.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $669.00 10-Q · filed 2015-08-13 | ||
| 2015-03-31 | -$838.00 10-Q · filed 2015-05-12 | |||
| 2014-12-31 | $5.09K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |